Catheter Precision, Inc. Comments on Recent Market Activity

Catheter Precision (NYSE American: VTAK), a medical device company specializing in electrophysiology products, has issued a statement addressing unusual trading activity in its stock.

Rhea-AI Summary

Catheter Precision (NYSE American: VTAK), a medical device company specializing in electrophysiology products, has issued a statement addressing unusual trading activity in its stock. The company explicitly stated it is unaware of any operational or company-related information that would explain the increased market activity. Management confirmed they are continuing to execute their previously disclosed strategic plans, including actively seeking financing to address their liquidity requirements.

Positive

• None.

Negative

• Company needs financing to meet liquidity needs, indicating potential cash flow concerns
• Unusual trading activity without fundamental business reasons could suggest market manipulation or speculation

Argus Session date unavailable

-28.35% session move Open Argus

Details

News Market Reaction – VTAK

The recorded move for VTAK in the trading session of this news was -28.35%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

FORT MILL, S.C., June 12, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE American: VTAK), a U.S.-based innovative medical device company focused on electrophysiology products, is issuing this press release in response to recent increases in trading activity in its common stock. The Company is not aware of any information related to the Company or its operations that it would have expected to cause increased market activity. The Company continues to pursue its strategic plans as previously disclosed, including its ongoing efforts to secure financing to meet its liquidity needs.

CONTACTS:

At the Company
David Jenkins
973-691-2000
IR@catheterprecision.com

# # #

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

Why did Catheter Precision (VTAK) issue a statement about market activity?

Catheter Precision issued the statement in response to unusual increases in trading activity of its common stock, stating they are unaware of any company-related information that would cause such activity.

What is Catheter Precision (VTAK) current financial situation?

The company disclosed they are actively seeking financing to meet their liquidity needs, suggesting potential cash flow concerns.

What business does Catheter Precision (VTAK) operate in?

Catheter Precision is a U.S.-based medical device company that focuses on developing and manufacturing electrophysiology products.

What strategic plans is VTAK currently pursuing?

The company stated they are continuing to pursue their previously disclosed strategic plans, with a particular focus on securing financing to address liquidity needs.